Drugs that contain Rizatriptan Benzoate
1. Maxalt patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5602162 (Pediatric) | ORGANON LLC | Imidazole, triazole and tetrazole derivatives |
Jul, 2012
(11 years ago) | |
|
US5298520 (Pediatric) | ORGANON LLC | Triazole containing indole derivatives |
Dec, 2012
(11 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Pediatric Exclusivity(PED) | Jun 16, 2015 |
| New Patient Population(NPP) | Dec 16, 2014 |
Market Authorisation Date: 29 June, 1998
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of MAXALT before it's drug patent expiration?
More Information on Dosage
MAXALT family patents
2. Maxalt-mlt patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5602162 (Pediatric) | ORGANON | Imidazole, triazole and tetrazole derivatives |
Jul, 2012
(11 years ago) | |
|
US5298520 (Pediatric) | ORGANON | Triazole containing indole derivatives |
Dec, 2012
(11 years ago) | |
| US5457895 | ORGANON | Method of identifying freeze-dried dosage forms |
Oct, 2013
(10 years ago) | |
|
US5457895 (Pediatric) | ORGANON | Method of identifying freeze-dried dosage forms |
Apr, 2014
(10 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Pediatric Exclusivity(PED) | Jun 16, 2015 |
| New Patient Population(NPP) | Dec 16, 2014 |
Market Authorisation Date: 29 June, 1998
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
How can I launch a generic of MAXALT-MLT before it's drug patent expiration?
More Information on Dosage
MAXALT-MLT family patents
3. Rizafilm patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US9301948 | GENSCO | Instantly wettable oral film dosage form without surfactant or polyalcohol |
Jul, 2034
(10 years from now) | |
Market Authorisation Date: 14 April, 2023
Treatment: NA
Dosage: FILM;ORAL
More Information on Dosage
RIZAFILM family patents